These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7560620)

  • 1. Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. The Registry Committee of the Society for Cardiac Angiography and Interventions.
    Kimmel SE; Berlin JA; Strom BL; Laskey WK
    J Am Coll Cardiol; 1995 Oct; 26(4):931-8. PubMed ID: 7560620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of success and major complications for primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. An analysis of the 1990 to 1994 Society for Cardiac Angiography and Interventions registries.
    Grassman ED; Johnson SA; Krone RJ
    J Am Coll Cardiol; 1997 Jul; 30(1):201-8. PubMed ID: 9207643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention.
    Krone RJ; Laskey WK; Johnson C; Kimmel SE; Klein LW; Weiner BH; Cosentino JJ; Johnson SA; Babb JD
    Am J Cardiol; 2000 May; 85(10):1179-84. PubMed ID: 10801997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention.
    Resnic FS; Ohno-Machado L; Selwyn A; Simon DI; Popma JJ
    Am J Cardiol; 2001 Jul; 88(1):5-9. PubMed ID: 11423050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators.
    Wolfe MW; Roubin GS; Schweiger M; Isner JM; Ferguson JJ; Cannon AD; Cleman M; Cabin H; Leya F; Bonan R
    Circulation; 1995 Aug; 92(3):311-9. PubMed ID: 7634443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and predictors of major in-hospital ischemic complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) registry.
    Hong MK; Popma JJ; Baim DS; Yeh W; Detre KM; Leon MB
    Am J Cardiol; 1997 Nov; 80(10A):40K-49K. PubMed ID: 9409691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of event and procedure rates following percutaneous transluminal coronary angioplasty in patients with and without previous coronary artery bypass graft surgery [the ROSETTA (Routine versus Selective Exercise Treadmill Testing after Angioplasty) Registry].
    Garzon P; Sheppard R; Eisenberg MJ; Schechter D; Lefkovits J; Goudreau E; Mak KH; Brown DL;
    Am J Cardiol; 2002 Feb; 89(3):251-6. PubMed ID: 11809424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients.
    Ruygrok PN; de Jaegere PT; van Domburg RT; van den Brand MJ; Serruys PW; de Feyter PJ
    J Am Coll Cardiol; 1996 Jun; 27(7):1669-77. PubMed ID: 8636552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study.
    Srinivas VS; Brooks MM; Detre KM; King SB; Jacobs AK; Johnston J; Williams DO
    Circulation; 2002 Sep; 106(13):1627-33. PubMed ID: 12270854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can restenosis after coronary angioplasty be predicted from clinical variables?
    Weintraub WS; Kosinski AS; Brown CL; King SB
    J Am Coll Cardiol; 1993 Jan; 21(1):6-14. PubMed ID: 8417077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris. A report of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
    Bentivoglio LG; Detre K; Yeh W; Williams DO; Kelsey SF; Faxon DP
    J Am Coll Cardiol; 1994 Nov; 24(5):1195-206. PubMed ID: 7930239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transluminal coronary angioplasty failures in patients with multivessel disease. Is there an increased risk?
    Wang N; Gundry SR; Van Arsdell G; Razzouk AJ; Hill AC; Sjolander M; Cavazos KA; Brewer JM; Vyhmeister EE; Bailey LL
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):214-21; discussion 221-3. PubMed ID: 7609545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes.
    Hannan EL; Arani DT; Johnson LW; Kemp HG; Lukacik G
    JAMA; 1992 Dec; 268(21):3092-7. PubMed ID: 1433740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography: results from the Registry of the Society for Cardiac Angiography and Interventions.
    Kimmel SE; Berlin JA; Hennessy S; Strom BL; Krone RJ; Laskey WK
    J Am Coll Cardiol; 1997 Jul; 30(1):193-200. PubMed ID: 9207642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set.
    Moscucci M; O'Connor GT; Ellis SG; Malenka DJ; Sievers J; Bates ER; Muller DW; Werns SW; Rogers EK; Karavite D; Eagle KA
    J Am Coll Cardiol; 1999 Sep; 34(3):692-7. PubMed ID: 10483949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
    Ellis SG; Vandormael MG; Cowley MJ; DiSciascio G; Deligonul U; Topol EJ; Bulle TM
    Circulation; 1990 Oct; 82(4):1193-202. PubMed ID: 2401060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG
    J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups.
    Hermans WR; Foley DP; Rensing BJ; Rutsch W; Heyndrickx GR; Danchin N; Mast G; Hanet C; Lablanche JM; Rafflenbeul W
    Am J Cardiol; 1993 Jul; 72(1):14-20. PubMed ID: 8517422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute coronary occlusion during percutaneous transluminal coronary angioplasty: experience of complications in a hospital without on site facilities for cardiac surgery.
    Richardson SG; Morton P; Murtagh JG; O'Keeffe DB; Murphy P; Scott ME
    BMJ; 1990 Feb; 300(6721):355-8. PubMed ID: 2106983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.